Chief Regulatory, Quality, Clinical Officer
GT Metabolic Solutions, Inc. (virtual), Minnesota, United States
Lisa Griffin Vincent, PhD MA, is Chief Regulatory, Quality, Clinical Officer at GT Metabolic Solutions, where she serves on the executive management team. GT Metabolic is the leader in development of magnetic compression anastomosis technologies, setting a new standard in minimally invasive surgery.
Dr. Vincent has expertise leading and growing functional talent and organizations along the product lifecycle, including research, clinical, regulatory, health economics, reimbursement, medical affairs, and market access. In addition, she has served in business leadership roles including, as chief operating officer for two global research companies, and as president of an outcomes research division. Her industry trajectory includes early-stage companies, such as Seismed Instruments, and PatientPoint, and large multinational organizations, such as UnitedHealth Group (UHG), Medtronic, BD, and GE Healthcare. Dr. Vincent has significant experience in the policy area and was appointed in January 2022 as an industry representative to the U.S. Department of Health and Human Services (DHHS) CMS Medicare Evidence Development and Coverage Advisory Committee (MEDCAC). Dr. Vincent holds a B.S. in nursing, M.A. in kinesiology, and Ph.D. in health services research and policy, all from the University of Minnesota. She was awarded full scholarships from the U.S. Agency for Health Care Policy and Research and DHHS for her doctoral training.
Breakout #3: Addressing 510(k) Review Challenges
Thursday, April 24, 2025
12:30 PM – 2:00 PM East Coast USA Time